コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 gionella pneumophila, the causative agent of Legionnaires disease.
2 an opportunistic human pathogen that causes Legionnaires disease.
3 therefore contribute to the establishment of Legionnaires disease.
4 that causes the potentially fatal pneumonia Legionnaires' Disease.
5 tive bacterial pathogen that is the cause of Legionnaires' Disease.
6 lveolar macrophages as a central property of Legionnaires' disease.
7 macrophages and causes the severe pneumonia Legionnaires' disease.
8 an alveolar macrophages and protozoa, causes Legionnaires' disease.
9 fection was assessed using a murine model of Legionnaires' disease.
10 umophila is a protozoan parasite that causes Legionnaires' disease.
11 a potentially fatal form of pneumonia named Legionnaires' disease.
12 t to be major factors in the transmission of Legionnaires' disease.
13 in the design of attenuated vaccines against Legionnaires' disease.
14 o replicate within mammalian cells and cause Legionnaires' disease.
15 ntified unsuspected patients with nosocomial legionnaires' disease.
16 for improved surveillance for travel-related Legionnaires' disease.
17 ost was investigated using a murine model of Legionnaires' disease.
18 of L. pneumophila responsible for 80% of all Legionnaires' disease.
19 g around two-thirds of all notified cases of Legionnaires' disease.
20 d causes a life-threatening pneumonia called Legionnaires' disease.
21 of the severe respiratory infection known as Legionnaires' disease.
22 ent for a severe atypical pneumonia known as Legionnaires' disease.
23 gionella pneumophila, the causative agent of Legionnaires' disease.
24 ssociated with community-acquired sources of Legionnaires' disease.
25 causative agent of a severe pneumonia called Legionnaires' disease.
26 sative agent of a severe pneumonia, known as Legionnaires' disease.
27 hila can result in a severe pneumonia called Legionnaires' disease.
28 ronmental bacterium and the leading cause of Legionnaires' disease.
29 c infection caused by Legionella bacteria is Legionnaires' disease.
30 d a metabolism-based blueprint for hampering Legionnaires' disease.
31 that cause a severe form of pneumonia called Legionnaires' disease.
32 la pneumophila, the major causative agent of Legionnaires' disease.
33 as source of infection resulting in cases of Legionnaires' disease.
34 agent of a severe form of pneumonia known as Legionnaires' disease.
35 acterization of the regional epidemiology of Legionnaires' disease.
36 CR is the most sensitive diagnostic tool for Legionnaires' disease.
37 cause of a severe pneumonia in humans called Legionnaires' disease.
38 iological agent of severe pneumonia known as Legionnaires' disease.
39 n that causes sporadic and epidemic cases of Legionnaires' disease.
40 agent of a severe form of pneumonia known as Legionnaires' disease.
41 causative agent of a severe pneumonia called Legionnaires' disease.
42 n result in the often fatal pneumonia called Legionnaires' disease.
43 f the severe and potentially fatal pneumonia Legionnaires' disease.
44 agent of a severe form of pneumonia known as Legionnaires' disease.
45 vivo in macrophages and in a mouse model of Legionnaires' disease.
46 hat causes an acute form of pneumonia called Legionnaires' disease.
47 cellular human pathogen that can cause fatal Legionnaires' disease.
48 the causative agent of the severe pneumonia Legionnaires' disease.
49 crophages, causing a severe pneumonia termed Legionnaires' disease.
50 an acute, potentially fatal pneumonia called Legionnaires' disease.
54 gionella pneumophila, the bacterial agent of Legionnaires' disease, a potentially fatal pneumonia acq
58 gionella pneumophila, the causative agent of Legionnaires' disease, a severe pneumonia, injects via a
60 tive intracellular parasite and the agent of Legionnaires' disease, acquires iron are largely unexpla
63 tigations were notable for first identifying Legionnaires disease and Pontiac fever, hantavirus pulmo
64 L. pneumophila is well known as the cause of Legionnaires' disease and a lesser form called Pontiac f
65 tant bacterium Legionella pneumophila causes Legionnaires' disease and employs a type IV secretion sy
66 tage for colonization of lung tissues during Legionnaires' disease and invasion of amoebas in the env
67 cause of a severe pneumonic illness known as Legionnaires' disease and is a global public health thre
68 context of the epidemiology of the pneumonia Legionnaires' disease and virulence mechanisms of Leishm
69 tic tests to accurately inform management of Legionnaires' disease, and controlled clinical trials to
70 between Legionella pneumophila, the agent of Legionnaires' disease, and hemin has received little att
71 ding the distribution and natural history of Legionnaires' disease, and inform outbreak investigation
72 nary proliferation in the A/J mouse model of Legionnaires' disease, and the defect is fully complemen
73 ay be a cost-effective method for control of Legionnaires' disease at the municipal level or in indiv
77 orming model than the gamma distribution for Legionnaires' disease based on data from a known outbrea
79 ila, the Gram-negative bacterium that causes Legionnaires' disease, can be cultured in the laboratory
83 st urinary antigen kits for the detection of Legionnaires' disease caused by organisms other than Leg
84 ila causes a severe form of pneumonia called Legionnaires' disease, characterized by bacterial replic
85 2008 to October 2010, there were 22 cases of Legionnaires' disease compared with 92 during November 2
86 nella pneumophila, the causative organism of Legionnaires' disease, contains a recently discovered no
88 onella pneumophila, the etiological agent of Legionnaires' disease, employs an arsenal of hundreds of
89 gionella pneumophila, the causative agent of Legionnaires' disease, employs the Dot/Icm T4SS to injec
90 nella pneumophila, the causative organism of Legionnaires' disease, encodes two virulence-associated
91 gionella pneumophila, the causative agent of Legionnaires' disease, expresses a type IVB secretion ap
92 Legionella pneumophila, the primary agent of Legionnaires' disease, flourishes in both natural and ma
93 to measure the increase in case detection of Legionnaires' disease following the introduction of rout
95 We hypothesize that the increase in reported Legionnaires' disease from June 2014 to November 2015 in
96 gionella pneumophila, the causative agent of Legionnaires' disease, grows within macrophages and mani
98 ver time, the prevalence of legionellosis or Legionnaires' disease has risen, which might indicate a
99 gionella pneumophila, the causative agent of Legionnaires disease, has a biphasic life cycle with a s
100 new diseases have been identified, including Legionnaires' disease, human immunodeficiency virus (HIV
101 sted in the two most relevant host cells for Legionnaires' disease, i.e., amoebae and macrophages.
102 erformance of different diagnostic tests for Legionnaires' disease in a clinical setting where Legion
105 ella pneumophila is the predominant cause of Legionnaires' disease in the United States and Europe, w
107 o 16.2, 95% Cl 2.8-351:7); risk of acquiring Legionnaires' disease increased by 64% (95% Cl 12-140) f
108 gionella pneumophila, the causative agent of Legionnaires disease, infects and replicates within huma
109 umophila, the Gram-negative pathogen causing Legionnaires' disease, infects host cells by hijacking e
110 usative agent of a severe pneumonia known as Legionnaires' disease, intercepts material from host cel
111 gionella pneumophila, the causative agent of Legionnaires' disease, invades and proliferates within a
116 e ability of Legionella pneumophila to cause Legionnaires' disease is dependent on its capacity to su
121 nella pneumophila, the causative organism of Legionnaires' disease, is a fresh-water bacterium and in
122 gionella pneumophila, the causative agent of Legionnaires' disease, is a ubiquitous freshwater bacter
124 nella pneumophila, the causative organism of Legionnaires' disease, is one of a small number of bacte
125 gionella pneumophila, the causative agent of Legionnaires' disease, is phagocytosed by alveolar macro
126 usative agent of a severe pneumonia known as Legionnaires' disease, it is likely that most infections
128 orphisms in TLR4 influence susceptibility to Legionnaires' disease (LD) by using a case-control study
131 r the past decade, the reported incidence of Legionnaires' disease (LD) in the northeastern United St
132 e cases associated with the South Bronx 2015 Legionnaires' disease (LD) investigation in New York Cit
136 ping of Lp1 isolates from sporadic cases and Legionnaires' disease (LD) outbreaks deposited into the
138 (LP) serogroup-1 (Lp1) is the major cause of Legionnaires' Disease (LD), a life-threatening pulmonary
140 ability of gastrointestinal illness (GI) and Legionnaires'disease (LD) were analyzed in QMRA models u
145 We investigated the genomic epidemiology of Legionnaires' disease over 36 years in Scotland, compari
146 These observations suggest a mechanism of Legionnaires' disease pathogenesis due to the presence o
147 nical relevance of these findings, we tested Legionnaires' disease patient sera for reactivity with t
148 aboratory evidence of infection) or probable Legionnaires' disease (pneumonia of undetermined cause).
149 7%) of 26 urine specimens from patients with Legionnaires' disease positive by the radioimmunoassay k
150 ella pneumophila, the gram-negative agent of Legionnaires' disease, possesses type IV pili and a type
153 gionella pneumophila, the bacterial agent of legionnaires' disease, replicates intracellularly within
154 Zealand, we compared the number of cases of Legionnaires' disease requiring hospitalization diagnose
156 erial pathogen and the causative organism of Legionnaires' disease, secretes a subset of protein effe
157 umophila (L.p.), the microbe responsible for Legionnaires' disease, secretes ~300 bacterial proteins
158 risk factors associated with development of Legionnaires' disease, such as smoking, produce a chroni
159 Review we outline the global epidemiology of Legionnaires' disease, summarise its diagnosis and manag
160 e more likely to have a reported outbreak of Legionnaires' disease than those that used water with mo
161 egies by assessing case attribution data for Legionnaires' disease, the environmental prevalence of L
163 gionella pneumophila, the causative agent of Legionnaires' disease, these processes are not well unde
164 onella pneumophila, the etiological agent of Legionnaires' disease, triggers activation of multiple i
165 athogen responsible for the severe pneumonia Legionnaires' disease, uses its dot/icm-encoded type IV
168 onella pneumophila is the causative agent of Legionnaires' disease, which is associated with intracel
169 f of 6 days will identify community-acquired Legionnaires' disease with a positive predictive value a
170 ed to 32 hospitals that had had outbreaks of Legionnaires' disease with the disinfection method for w